S&P 500
5.161,16 +33,37 (+0,65%) Nasdaq
16.272,46 +116,13 (+0,72%) NIKKEI 225
38.236,07 -38,03 (-0,10%) Dólar/Euro
1,0778 +0,0012 (+0,11%) Petróleo Brent
83,23 +0,27 (+0,33%) Bitcoin EUR
58.789,75 -1.019,69 (-1,70%)
Lucy Scientific Discovery Inc. (LSDI)
Lucy Scientific Discovery Inc.
1321 Blanshard Street
Suite 301
Victoria, BC V8W 0B6
Canada
778-410-5195
https://www.lucyscientific.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 2
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Richard D. Nanula | CEO & Executive Chair | 41,66k | N/A | 1961 |
| Mr. Brian Zasitko C.A., CPA | Chief Financial Officer | 100k | N/A | 1981 |
| Mr. Scott Michael Reeves L.L.B. | Corporate Secretary & Director | N/A | N/A | 1970 |
Descripción
Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.
Gobierno corporativo
El ISS Governance QualityScore de Lucy Scientific Discovery Inc., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
